Gencaro(TM)'s Norepinephrine Lowering Likely Contributes to Its Effect in ... MarketWatch (press release) ... today announced results of analyses of atrial fibrillation (AF) data from the BEST trial, a previously conducted Phase 3 heart failure (HF) trial involving Gencaro (bucindolol hydrochloride), in 2708 advanced heart failure patients. |
